---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-125959"
form_type: "8-K"
ticker: "ALUR"
cik: "0001964979"
company_name: "ALLURION TECHNOLOGIES, INC."
filed_at: "2024-11-13T23:59:59+00:00"
generated_at: "2026-05-30T01:18:28.550282+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Allurion Q3 revenue $5.4M, down 70% YoY; FY2024 guidance cut to $30-35M

## Summary
- Revenue $5.4M vs $18.2M prior year, includes $1.2M France recall charge; gross margin fell to 58% from 77%.
- Full-year 2024 revenue guidance lowered to $30-35M; expects flat procedure volume growth YoY.
- Restructuring reduces workforce & opex ~50%; $3.5M charges in Q4, targeting profitability by end of 2025.
- AI VCS revenue up 82% YoY; AUDACITY top-line readout expected by year-end after last patient exited.
- Three of four PMA modules filed for Allurion Balloon; France remediation plan completed in September.

## SEC filing metadata
- accession: 0000950170-24-125959
- form_type: 8-K
- ticker: ALUR
- cik: 0001964979
- company_name: ALLURION TECHNOLOGIES, INC.
- filed_at: 2024-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964979/000095017024125959/0000950170-24-125959-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964979/000095017024125959/alur-20241113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-125959
- JSON: https://secwatch.observer/filing/0000950170-24-125959.json
- Plain text: https://secwatch.observer/filing/0000950170-24-125959.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.